Patients With Congenital Myasthenic Syndrome Will be Treated With Mesenchymal Stem Cell Exosome Solution
Clinical trial NCT07226726 · RECRUITING
Trial details
- NCT number
- NCT07226726
- Sponsor
- The Foundation for Orthopaedics and Regenerative Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-01
- Primary completion
- 2028-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.